J
Jack
St. Jude Medical Announces First European Commercial Implant of Toronto SPV II Tissue Heart Valve
ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 16, 2004--St. Jude Medical, Inc. (NYSE:STJ) today announced the first commercial European implant of the Toronto SPV(R) II tissue heart valve, the Company's next-generation aortic stentless tissue valve.
St. Jude Medical Announcment
ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 16, 2004--St. Jude Medical, Inc. (NYSE:STJ) today announced the first commercial European implant of the Toronto SPV(R) II tissue heart valve, the Company's next-generation aortic stentless tissue valve.
St. Jude Medical Announcment
